Connect with us

The Conversation

Whooping cough is making a comeback, but the vaccine provides powerful protection

Published

on

theconversation.com – Annette Regan, Adjunct Associate Professor of Epidemiology, University of California, Los Angeles – 2025-04-29 07:47:00

Infants can get vaccinated against whooping cough starting at 6 weeks of age.
Hill Street Studios/Corbis via Getty Images

Annette Regan, University of California, Los Angeles

Whooping cough, a bacterial infection that can be especially dangerous for babies and young children, is on the rise. Already in 2025 the U.S. has recorded 8,485 cases. That’s compared with 4,266 cases during the same period in 2024.

Like measles, which is also spreading at unprecedented levels, whooping cough, more formally known as pertussis, can be prevented by a safe
and effective vaccine. But with anti-vaccine sentiment increasing and cuts to immunization services, vaccination rates for whooping cough over the past two years have declined in children.

The Conversation asked epidemiologist Annette Regan to explain why pertussis has become so prevalent and how families can protect themselves from the disease.

What is pertussis and why is it dangerous?

Pertussis is a vaccine-preventable disease caused by the bacterium Bordetella pertussis. Researchers in France first identified the B. pertussis bacterium in 1906. The first recorded epidemic of pertussis is thought to have occurred in Paris in 1578.

Infection can cause an acute respiratory illness characterized by severe and spasmodic coughing spells. The classic symptom of pertussis is a “whoop” sound caused by someone trying to breath during a bad cough. Severe complications of pertussis include slowed or stopped breathing, pneumonia and seizures. The disease is most severe in young babies, although severe cases and deaths can also occur in older children and adults.

Some doctors call pertussis “the 100-day cough” because symptoms can linger for weeks or even months.

The World Health Organization estimates that 24.1 million pertussis cases and 160,700 deaths occur worldwide in children under 5 each year. Pertussis is highly contagious. Upon exposure, 80% of people who have not been previously exposed to the bacterium or vaccinated against the disease will develop an infection.

Fortunately, the disease is largely preventable with a safe and effective vaccine, which was first licensed in the U.S. in 1914.

YouTube video
Whooping cough causes violent fits of coughing that can make it difficult to inhale.

How do cases last year and this year compare with past years?

During the COVID-19 pandemic between 2020 and 2022, pertussis cases were lower than usual. This may have been a result of limited social contact due to social distancing, masking, school closures and lockdown measures, which reduced the spread of disease overall.

In the past two years, however, pertussis cases have surpassed figures from before the pandemic. In 2024, local and state public health agencies reported 35,435 pertussis cases to the Centers for Disease Control and Prevention – a rate five times higher than the 7,063 cases reported in 2023 and nearly double the 18,617 cases reported in 2019 prior to the pandemic.

Between October 2024 and April 2025, at least four people in the U.S. have died of pertussis: two infants, one school-age child and one adult.

Why are pertussis cases rising?

Although vaccines have resulted in a dramatic decline in pertussis infections in the U.S., incidence of the disease has been rising since the 1990s, except for a brief dip during the COVID-19 pandemic.

Before the start of routine childhood vaccination for pertussis in 1947, its rates hovered between 100,000 and 200,000 cases per year. With vaccines, rates plunged under 50,000 annually by the late 1950s and under 10,000 per year in the late 1960s. They reached a low of 1,010 cases in 1976.

Starting in the 1980s and 1990s, however, the U.S. and several other countries have been seeing a steady resurgence of pertussis cases, which have exceeded 10,000 cases in the U.S. every year from 2003 to 2019. They dropped again during the pandemic until last year’s resurgence.

There is no single explanation for why cases have been rising recently, but several factors probably contribute. First, pertussis naturally occurs in cyclic epidemics, peaking every two to five years. It is possible that the U.S. is headed into one of these peaks after a period of low activity between 2020 and 2022. However, some scientists have noted that the increase in cases is larger than what would be expected during a usual peak.

Man holding up two test tubes of blood in a laboratory
A public health worker processes blood samples during a whooping cough outbreak in Ohio in December 2010.
National Institute for Occupational Safety and Health

Some scientists have noted that this apparent resurgence correlates with a change in the type of vaccine used in children. Until the 1990s, the pertussis vaccine contained whole, killed B. pertussis bacteria cells. Whole-cell vaccine can stimulate a long-lasting immune response, but it is also more likely to cause fever and other vaccine reactions in children.

In the 1990s, national vaccine programs began to transition to a vaccine that contains purified components of the bacterial cell but not the whole cell. Some scientists now believe that although this partial-cell vaccine is less likely to cause high fevers in children, it provides protection for a shorter time. Immunity after whole-cell vaccination is thought to last 10-12 years compared with three to five years after the partial-cell vaccine. This means people may become susceptible to infection more quickly after vaccination.

Vaccination rates are also not as high as they should be and have started falling in children since 2020. In the U.S., the percent of kindergartners who are up to date with recommended pertussis vaccines has declined from 95% during the 2019-20 school year to 92% in the 2023-24 school year. Even fewer adolescents receive a booster dose.

How can people protect themselves and their families?

Routine vaccination for children starting in infancy followed by booster doses in adolescents and adults can help keep immunity high.

Public health experts recommend that children receive five doses of the pertussis vaccine. According to the recommendations, they should receive the first three doses at 2, 4 and 6 months of age, then two additional doses at 15 months and 4 years of age, with the aim of providing protection through early adolescence.

Infants younger than 6 weeks are not old enough to get a pertussis vaccine but are at the greatest risk of severe illness from pertussis. Vaccination during pregnancy can offer protection from birth due to antibodies that pass from the mother to the developing fetus. Many countries, including the U.S., now recommend that women receive one dose of pertussis vaccine between the 27th and 36th week of every pregnancy to protect their babies.

To maintain protection against pertussis after childhood, a booster dose of pertussis vaccine is recommended for adolescents at 11 to 12 years of age. The CDC recommends that all adults receive at least one booster dose.

Young boy receives a vaccine
The pertussis vaccine’s protction wanes over time, so public health experts recommend a booster around age 11 or 12.
SELF Magazine via flickr, CC BY

Because immunity declines over time, people who are in contact with infants and other high-risk groups, such as caregivers, parents and grandparents, may benefit from additional booster doses. When feasible, the CDC also recommends a booster dose for adults 65 years and older.

Vaccine safety studies over the past 80 years have proven the pertussis vaccine to be safe. Around 20% to 40% of vaccinated infants experience local reactions, such as pain, redness and swelling at the vaccination site, and 3% to 5% of vaccinated infants experience a low-grade fever. More severe reactions are much less common and occur in fewer than 1% of vaccinated infants.

The vaccine is also highly effective: For the first year after receiving all five doses of the pertussis vaccine, 98% of children are protected from pertussis. Five years after the fifth dose, 65% of vaccinated children remain protected.

Booster vaccination during adolescence protects 74% of teens against pertussis, and booster vaccination during pregnancy protects 91% to 94% of immunized babies against hospitalization due to pertussis.

Families can talk to their regular health care providers about whether a pertussis vaccine is needed for their child, themselves or other family members.The Conversation

Annette Regan, Adjunct Associate Professor of Epidemiology, University of California, Los Angeles

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Whooping cough is making a comeback, but the vaccine provides powerful protection appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Center-Left

The content has a Center-Left political bias as it emphasizes public health measures such as vaccination and vaccination programs, highlighting the dangers of vaccine hesitancy and cuts to immunization services. It relies heavily on scientific data and expert opinions to explain whooping cough and the importance of vaccines, while implicitly criticizing reductions in public health funding and vaccine skepticism typically associated with conservative policies. However, the tone remains generally factual and non-partisan, focusing on health outcomes rather than overt political rhetoric, which places it slightly left of center but still largely mainstream in its approach.

The Conversation

Making eye contact and small talk with strangers is more than just being polite − the social benefits of psychological generosity

Published

on

theconversation.com – Linda R. Tropp, Professor of Social Psychology, UMass Amherst – 2025-05-21 08:00:00


In today’s world, many people engage minimally with others in public spaces, often distracted by technology or personal interests. This trend leads to isolation, despite advances in technology. People tend to focus on self-relevant information, which may cause them to overlook opportunities for social connection. Small behaviors, such as making eye contact or initiating small talk, can foster connections and make others feel seen. Practicing “psychological generosity” involves being mindful of how attention is used and intentionally engaging with others, promoting social relationships and community well-being. Simple gestures like smiling or greeting someone can help build a sense of belonging.

Eyes down, headphones on – what message are you sending?
vm/E+ via Getty Images

Linda R. Tropp, UMass Amherst

How much do you engage with others when you’re out in public? Lots of people don’t actually engage with others much at all. Think of commuters on public transportation staring down at their phones with earbuds firmly in place.

As a professor of social psychology, I see similar trends on my university campus, where students often put on their headphones and start checking their phones before leaving the lecture hall on the way to their next class.

Curating daily experiences in these ways may appeal to your personal interests, but it also limits opportunities for social connection. Humans are social beings: We desire to feel connected to others, and even connecting with strangers can potentially boost our mood.

Though recent technological advances afford greater means for connection than at any other moment in human history, many people still feel isolated and disconnected. Indeed, loneliness in the American population has reached epidemic levels, and Americans’ trust in each other has reached a historic low.

At the same time, our attention is increasingly being pulled in varied directions within a highly saturated information environment, now commonly known as the “attention economy.”

It is perhaps not surprising, then, that so many Americans are experiencing a crisis of social connection. Research in social psychology helps to explain how the small behaviors and choices we make as individuals affect our experiences with others in public settings.

Where you focus your attention

One factor shaping people’s experiences in public settings concerns where they focus their attention. Since there is more information out in the world than anyone could ever realistically take in, people are driven to conserve their limited mental resources for those things that seem most crucial to navigating the world successfully. What this means is that every person’s attention is finite and selective: By attending to certain bits of information, you necessarily tune out others, whether you’re aware of doing so or not.

More often than not, the information you deem worthy of attention also tends to be self-relevant. That is, people are more likely to engage with information that piques their interest or relates to them in some way, whereas they tend to ignore information that seems unrelated or irrelevant to their existence.

These ingrained tendencies might make logical sense from an evolutionary perspective, but when applied to everyday social interaction, they suggest that people will limit their attention to and regard for other people unless they see others as somehow connected to them or relevant to their lives.

One unfortunate consequence is that a person may end up treating interactions with other people as transactions, with a primary focus on getting one’s own needs met, or one’s own questions answered. A very different approach would involve seeing interactions with others as opportunities for social connection; being willing to expend some additional mental energy to listen to others’ experiences and exchange views on topics of shared interest can serve as a foundation for building social relationships.

young woman walks past a young man who is staring down at his phone
It can feel alienating to be surrounded by people who have basically hung out a ‘do not disturb’ sign.
Drazen/E+ via Getty Images

How others interpret your actions

Also, by focusing so much attention on their own individual interests, people may inadvertently signal disinterest to others in their social environments.

As an example, imagine how it would feel to be on the receiving end of those daily commuting rituals. You find yourself surrounded by people whose ears are closed off, whose eyes are down and whose attention is elsewhere – and you might start to feel like no one really cares whether you exist or not.

As social creatures, it’s natural for human beings to want to be seen and acknowledged by other people. Small gestures such as eye contact or a smile, even from a stranger, can foster feelings of connection by signaling that our existence matters. Instead, when these signals are absent, a person may come to feel like they don’t matter, or that they’re not worthy of others’ attention.

How to foster connection in public spaces

For all these reasons, it may prove valuable to reflect on how you use your limited mental resources, as a way to be more mindful and purposeful about what and who garner your attention. As I encourage my students to do, people can choose to engage in what I refer to as psychological generosity: You can intentionally redirect some of your attention toward the other people around you and expend mental resources beyond what is absolutely necessary to navigate the social world.

Engaging in psychological generosity doesn’t need to be a heavy lift, nor does it call for any grand gestures. But it will probably take a little more effort beyond the bare minimum it typically takes to get by. In other words, it will likely involve moving from being merely transactional with other people to becoming more relational while navigating interactions with them.

A few simple examples of psychological generosity might include actions such as:

  • Tuning in by turning off devices. Rather than default to focusing attention on your phone, try turning off its volume or setting it to airplane mode. See if you notice any changes in how you engage with other people in your immediate environment.

  • Making eye contact and small talk. As historian Timothy Snyder writes, eye contact and small talk are “not just polite” but constitute “part of being a responsible member of society.”

  • Smiling and greeting someone you don’t know. Take the principle of “innocent until proven guilty” to the realm of social relations, by showing your willingness to welcome other people rather than displaying disinterest and avoidance. Such simple acts may help to foster feelings of belonging and build a sense of community with others.

Woman taps her bus pass and smiles at the driver
Acknowledging another human with a smile, even when using an automated system, can help them feel seen and valued.
izusek/E+ via Getty Images

Among the most cynical, examples like these may initially be written off as reflecting pleas to practice the random acts of kindness often trumpeted on bumper stickers. Yet acts like these are far from random – they require intention and redirection of your attention toward action, like any new habit you may wish to cultivate.

Others might wonder whether potential benefits to society are worth the individual cost, given that attention and effort are limited resources. But, ultimately, our well-being as individuals and the health of our communities grow from social connection.

Practicing acts of psychological generosity, then, can provide you with opportunities to benefit from social connection, at the same time as these acts can pay dividends to other people and to the social fabric of your community.The Conversation

Linda R. Tropp, Professor of Social Psychology, UMass Amherst

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Making eye contact and small talk with strangers is more than just being polite − the social benefits of psychological generosity appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Centrist

This content is primarily focused on social psychology and the importance of interpersonal connection in public spaces. It does not advocate for any particular political ideology or party, nor does it touch on divisive political issues. Instead, it emphasizes universal human experiences and promotes modest behavioral changes to enhance social well-being, which aligns with a neutral, centrist perspective.

Continue Reading

The Conversation

WHO is finalizing a new treaty that prepares for the next pandemic − but the US isn’t signing

Published

on

theconversation.com – Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York – 2025-05-22 07:49:00


In March 2025, the World Health Organization adopted the world’s first pandemic agreement, aiming to improve global pandemic preparation. Countries committing to the accord will enhance disease surveillance, healthcare workforces, regulatory systems, and invest in research and development. The agreement also includes mechanisms for vaccine production and distribution. The U.S. withdrew from negotiations, partly due to concerns over sovereignty and pharmaceutical industry profits, but its absence may have made the treaty more equitable, particularly for developing countries. The agreement could improve access to vaccines and treatments, benefiting both rich and poor nations in future pandemics.

The 78th World Health Assembly is taking place in Geneva, Switzerland, from May 19-27, 2025.
Fabrice Coffrini/AFP via Getty Images

Nicole Hassoun, Binghamton University, State University of New York

On March 20, 2025, members of the World Health Organization adopted the world’s first pandemic agreement, following three years of “intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.” The U.S., however, did not participate, in part because of its intention to withdraw from the WHO.

Global health experts are hailing the agreement as a historic moment.

What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic?

The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.’s absence from it.

What will the pandemic agreement do?

The accord will bolster pandemic preparation within individual countries and around the world.

Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts.

It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly.

The agreement will take effect once enough countries ratify it, which may take several years.

Why isn’t the US involved?

The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations.

Prior to Donald Trump’s reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank’s concerns about U.S. sovereignty.

The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term.

Why could the lack of US involvement be beneficial for the world?

The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions.

It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry’s profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures.

Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies.

While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines.

How could the agreement broaden access for treatments?

One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed.

Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world.

The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries.

If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives.

What more should be done, and does the US have a role to play?

In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID.

Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics.

It will also be imperative for member countries to provide funding to support the agreement’s goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people’s arms.The Conversation

Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post WHO is finalizing a new treaty that prepares for the next pandemic − but the US isn’t signing appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Center-Left

This content presents a generally supportive view of international cooperation and global health initiatives, emphasizing equitable vaccine access and criticizing the U.S. withdrawal from the WHO under a previous administration. It frames U.S. opposition mainly in terms of protecting pharmaceutical profits and sovereignty concerns, which aligns with typical center-left critiques of market priorities over public good. The overall tone favors multilateralism, public health investment, and global equity, without being overtly partisan or ideological, situating the piece in a center-left perspective.

Continue Reading

The Conversation

Lifecycle of a research grant – behind the scenes of the system that funds science

Published

on

theconversation.com – Kelly S. Mix, Associate Dean for Research, Innovation, and Partnerships in the College of Education, University of Maryland – 2025-05-22 07:44:00


Science funding involves a rigorous, multi-stage process ensuring responsible use of grants. Researchers submit applications responding to specific requests for proposals (RFPs) from agencies like NIH and NSF, outlining their project’s need and research plan. Applications undergo triage for compliance, then a thorough merit review by anonymous content experts who evaluate innovation, methodology, and impact. Reviewers disclose conflicts of interest and participate in confidential panel discussions to reach fair scores. Funding decisions rely on these evaluations, with program staff making final calls. Universities enforce strict spending rules, monitoring expenses via approvals, receipts, and audits to maintain integrity and future funding access.

Without grants for salaries, supplies and more, many research labs would be empty.
Solskin/DigitalVision via Getty Images

Kelly S. Mix, University of Maryland

Science funding is a hot topic these days and people have questions about how grants work. Who decides whether a researcher will receive funds? What’s the decision-making process? How is the money spent once a grant proposal has been approved?

As a veteran academic researcher, department chairperson and associate dean for research, I have seen this process play out from multiple perspectives – as a grant recipient, grant reviewer and university administrator.

Research organizations and major federal funders, including the National Institutes of Health, the National Science Foundation and the Defense Advanced Research Projects Agency (DARPA), all rely on careful systems of checks and balances to ensure high standards of scholarship and financial integrity at every stage of a grant’s lifecycle. Here’s how it all works.

The birth of a grant application

To receive research funding, scientists submit grant applications to specific programs. A cancer researcher might apply to the Bioengineering Research Grants program at NIH. Someone investigating sustainable fishing in freshwater habitats could seek funding from the Population and Community Ecology program at the NSF.

Applications must be responsive to the funding program’s specific request for proposals, or RFP. The RFP tells researchers what the agency wants to fund. For example, the NSF’s Education Core Research program currently only funds projects focused on STEM learning.

RFPs might have other application requirements, too, like explaining how a project will contribute to the public good, or supporting training for new scientists.

Grant applications have two main parts. First, the researcher presents an extensive literature review to explain why the new project is needed and what it will add to the existing knowledge base. Next, they write up a detailed description of the proposed research plan. This basic two-part structure ensures that funded research will yield important information that is both new and trustworthy.

Reviewers read the grant applications and compare them to the RFP. Applications that don’t address all the topics and research priorities listed there are unlikely to be funded. I once had a proposal rejected without further review because I left out a paragraph addressing one of the items in the agency’s new RFP. This initial review for RFP compliance is called “triage” and, believe me, nobody wants to see their hard work triaged out of the running.

out of focus view of several people seated and standing around a conference table
A panel of anonymous content experts carefully reviews applications to see if they’re worth funding.
PeopleImages/iStock via Getty Images Plus

Merit review: How funding decisions are made

Federal funding decisions are made through rigorous merit review.

For each round of funding, agencies assemble a panel of anonymous content experts who will look for strengths and weaknesses in the proposals – anything from innovation in the question posed to logical flaws in the hypotheses or technical problems with the planned data analyses. With a group of experts looking for every possible weakness, having your grant reviewed is a bit like running a gauntlet.

This careful review might help explain why 70% to 80% of grant applications typically go unfunded at agencies like the NIH and the NSF. But this level of scrutiny is necessary to prevent funding poorly designed or low-impact research.

Several safeguards head off bias or unethical influences during merit review.

First, reviewers must disclose any conflicts of interest with the pool of applicants before they can access the applications. Conflicts of interest can include situations like the reviewer having been the student of an applicant, the applicant and reviewer being divorced, or the proposal coming from the reviewer’s current institution.

When conflicts are identified, the reviewer can remain on the panel, but they are completely excluded from decisions related to that application. They cannot even be in the room when it is discussed.

Second, reviewers usually attend a meeting, supervised by program staff from the funding agency, where everyone debates the proposal’s merits before they score it. Sometimes panel members disagree in their initial critiques and use the meeting to hash out their differences. Other times, a reviewer might raise an important concern that others missed.

Group discussion helps ensure a transparent and thorough review. It also stops any single reviewer from dictating the fate of a proposal because everyone hears the discussion and then scores the proposal individually. Whether a reviewer thinks an application is outstanding or fatally flawed, they must convince the rest of the experts in the room for the group’s overall scores to be greatly affected.

Third, these discussions, along with the applications themselves and any written critiques, are strictly confidential. Reviewers sign written confidentiality agreements under penalty of perjury. This practice stops panelists from scoring political points by telling an applicant they defended their proposal, or divulging trade secrets and proprietary information.

Following the meeting, final decisions are made by program staff using the reviewers’ evaluations. Some agencies adhere closely to the reviewers’ numeric scores – like a grade – when making these decisions. Others ask reviewers to sort applications into “fundable” or “non-fundable” piles; program staff then have some discretion on the final decision. But all decisions are rooted in the peer critiques.

chest of someone seated at desk with calculator and a lot of receipts
Researchers and their institutions keep careful records of where every penny gets spent.
krisanapong detraphiphat/Moment

Spending the funds

Headlines about universities receiving large grants may leave the impression that such funds are simply added to the institution’s general coffers. But research funds are granted to support specific research projects, and agencies have strict rules about spending the money.

For example, if a researcher wants to present their findings at a conference, they can charge the grant for their travel costs, but they may not charge above a certain amount for their lodging or purchase business class airplane tickets. Similarly, if a researcher wants to have more time to devote to a funded project, they can use part of the money to pay their own salary in the summer, but there are precise limits on the amount of funding that can be used for this purpose.

It’s not up to the researcher alone to follow these rules. The organization that employs the researcher, usually a university, enforces the agency rules because it’s the employing organization that controls the grant accounts.

Returning to the conference travel example, a university researcher who wants to attend a conference must request permission and provide a budget for the trip before purchasing tickets. If the travel request is approved by their department chair, dean and the university travel office, they may go ahead with their reservations. However, if they don’t produce receipts when they return, they will not be allowed to charge the grant. The same process applies to buying new computers for the lab, ordering standardized tests for a study or purchasing gift cards for study participants.

Research organizations are highly motivated to enforce spending rules properly, because everyone in the organization is at risk of losing access to federal funds in the future if they let things slide. Funding agencies also require periodic reports and sometimes conduct audits to ensure compliance. These practices help guard against any misuse of funds.

The way agencies issue grants to researchers isn’t perfect. But processes like issuing detailed RFPs, conducting merit reviews and monitoring financial compliance go a long way toward protecting the integrity of the research funding process.The Conversation

Kelly S. Mix, Associate Dean for Research, Innovation, and Partnerships in the College of Education, University of Maryland

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Lifecycle of a research grant – behind the scenes of the system that funds science appeared first on theconversation.com



Note: The following A.I. based commentary is not part of the original article, reproduced above, but is offered in the hopes that it will promote greater media literacy and critical thinking, by making any potential bias more visible to the reader –Staff Editor.

Political Bias Rating: Centrist

This article presents a factual, procedural explanation of how research funding works in the United States, focusing on the systems, checks, and safeguards in place for grant application, review, and spending. It avoids ideological language or partisan framing, instead emphasizing transparency, merit-based decision-making, and accountability within federal funding agencies. The tone is neutral and informational, intended to clarify a complex process rather than advocate for any political viewpoint. Overall, the content reflects a balanced, nonpartisan stance centered on explaining government operations in research funding.

Continue Reading

Trending